Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lucy Scientific Discovery Inc LSDI

Healthcare
Lucy Scientific Discovery Inc. is an early stage psychotropics contract manufacturing company. The Company is engaged in researching, developing, and manufacturing psychotropic drugs. The Company is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. It is focused on... see more

Recent & Breaking News (NDAQ:LSDI)

Lucy Scientific Discovery Inc. Announces Sponsorship at the Psychedelic Science Conference June 19-25, 2023

GlobeNewswire May 19, 2023

Lucy Scientific Discovery Inc. Accelerates Psilocybin Access and Product Launch through a Strategic Partnership with TheraPsil

GlobeNewswire May 18, 2023

Lucy Scientific Discovery Announces Share Repurchase Program

GlobeNewswire April 6, 2023

Lucy Scientific Discovery Appoints Former B.C. Solicitor General Kash Heed as a Special Advisor

GlobeNewswire March 29, 2023

Lucy Scientific Discovery Announces Partnership with High Times® to Develop and Distribute a New Line of Psychoactive Products

GlobeNewswire March 23, 2023

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

GlobeNewswire March 21, 2023

Lucy Scientific to Acquire SANA-013 Psychedelic Assets from Drug Developer Wesana Health

GlobeNewswire March 21, 2023

Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities

GlobeNewswire March 17, 2023

Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs

GlobeNewswire February 27, 2023

WestPark Capital Announces Closing of $7.5 Million IPO for Lucy Scientific Discovery Inc. (NASDAQ:LSDI)

Business Wire February 22, 2023

Lucy Scientific Discovery Files Amendment with Health Canada to Expand its List of Controlled Substances to Include Cocaine and Heroin; This Expansion Represents an Effort to Supply Harm Reduction Programs Around the World

GlobeNewswire February 16, 2023

Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO

GlobeNewswire February 16, 2023

Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering

GlobeNewswire February 13, 2023